Alternate Warm and Cold Therapy (AWCT) on Uricemia, Sleep, Pain, Functional Ability, and Quality of Life (USPFQoL) in Patients with Gout: A Path Forward.

Journal: Journal of healthcare engineering

Volume: 2022

Issue: 

Year of Publication: 2022

Affiliated Institutions:  College of Nursing, Mahalah Branch for Girls King Khalid University, Abha, Asir, Saudi Arabia. Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Asir, Saudi Arabia. College of Nursing, Mahalah Branch for Girls, King Khalid University, Abha, Asir, Saudi Arabia. Department of Anesthesia Technology, College of Applied Medical Sciences in Jubail, Imam Ab-dulrahman Bin Faisal University, P.O. Box , Jubail, Saudi Arabia. Department of Basic Medical Sciences, College of Medicine, Almaarefa University, P.O. Box , Riyadh , Saudi Arabia. Georgia CTSA, Emory University Hospital, Atlanta, GA, USA. Lecturer in Mental Health Nursing, Oxford School of Nursing & Midwifery, Faculty of Health and Life Sciences, Oxford OX FL, UK. Medical Surgical Nursing, College of Nursing Tanta University, Egypt and College of Nursing, Mahalah Branch for Girls King Khalid University, Asir, Saudi Arabia. Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk , Saudi Arabia. Department of Chemical Engineering, College of Biological and Chemical Engineering, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.

Abstract summary 

To understand the impact of alternate warm and cold therapy (AWCT) on uricemia, sleep, pain, functional ability, and quality of life in gout patients.A quasiexperimental, nonequivalent control group, pre and posttest design was adopted among 120 gout patients. The data were collected on demographics, comorbidities, pain level, joint swelling/joint tenderness, patient global assessment of response to treatment (PGART), health-related quality of life (HRQoL) with SF-36, sleep quality by Pittsburgh Sleep Quality Index (PSQI), and serum uric acid and assessed. Descriptive and inferential statistics were used to analyze the data.Patients had mean age of 58 and 61 years, mean number of comorbidities was 1.8 and 1.4, as well as presence of arthritic comorbidities except gout was 1.1 and 0.8 among study and control group participants, respectively. Pain ( < 0.001), PGART (=-0.01), HRQoL, sleep quality, and level of SUA (mg/dl) improved significantly ( < 0.01) among the study group over study periods. It affirms that the AWCT is effective in reducing pain, functional disability, and SUA, as well as improving the sleep quality and HRQoL of the gout patients. There was a reduced incidence of gout flares ( < 0.001), and taking additional medicines for pain ( < 0.01) was statistically significant among study participants. Except social functioning, other domains of health were significantly ( < 0.05) affected by the comorbidities like hypertension, diabetes, heart disease, renal disease, and asthma/chronic obstructive pulmonary disease.Gout is independently associated with higher medical and arthritic comorbidity, and AWCT can be better and cost-effective alternative therapy for gout patients. In addition, it may lead to improved cardiac function, hypertension, and renal insufficiency.

Authors & Co-authors:  Paulsamy Premalatha P Venkatesan Krishnaraju K Alshahrani ShadiaHamoud S Ahmad Fazil F El-Sherbiny Mohamed M Manoharan Vani V Periannan Kalaiselvi K Ahmed RashaElsayed R Prabahar Kousalya K Mamiru Teressa Dawit D

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Roubenoff R. Gout and hyperuricemia. Rheumatic Disease Clinics of North America . 1990;16(3):539–550. doi: 10.1016/s0889-857x(21)00887-5.
Authors :  10
Identifiers
Doi : 5471575
SSN : 2040-2309
Study Population
Male,Female
Mesh Terms
Cryotherapy
Other Terms
Study Design
Case Control Trial,Descriptive Study,Cross Sectional Study
Study Approach
Country of Study
Publication Country
England